American Water Secures Its First Navy Contract
American Water Works Company Inc’s (NYSE:AWK) Military Services Group has secured a contract for the ownership, operation, maintenance, and replacement of…
Why Borqs Technologies Shares Are Gaining Today
Borqs Technologies, Inc’s (NASDAQ:BRQS) solar energy storage systems subsidiary, Holu Hou Energy LLC (HHE), collaborated with developers and property owners for…
Embraer Collaborates With Toyota To Maximize Production System Efficiency
Embraer SA (NYSE:ERJ) has signed an agreement with Toyota Motors Corp (NYSE:TM) Toyota do Brasil to embrace Toyota Production System (TPS) principles and…
Oxford Biomedica Inks New Three Year Deal To Make AstraZeneca’s COVID-19 Vaccine
Oxford Biomedica plc (OTC:OXBDF) signed a new three-year agreement to potentially make AstraZeneca Plc’s (NASDAQ:AZN) COVID-19 vaccine beyond 2022. The new agreement represents…
Oxford Biomedica Signed New Three year Agreement with AstraZeneca
Oxford Biomedica plc (LSE:OXB) ("Oxford Biomedica" or "the Company"), a leading gene and cell therapy group, today announces that it has signed a new three year Master Services & Development Agreement ("the Agreement") with AstraZeneca UK Ltd ("AstraZeneca") which would facilitate potential future manufacturing opportunities for the AstraZeneca COVID-19 vaccine.